Testing effectiveness (Phase 2)Study completedNCT04868708
What this trial is testing
AK104( an Anti-PD-1 and Anti-CTLA-4 Bispecific Antibody) in Recurrent or Metastatic Cervical Cancer
Who this might be right for
Recurrent or Metastatic Cervical Cancer
Akeso 50